FeesSafety
Pluang+

Bitcoin buying strategy debated: buy only in extreme fear vs. regular dollar-cost averaging.

Market News
10 Nov 2026, 14:28 WIB
Tokenpost
View Source
Neutral
Bitcoin buying strategy debated: buy only in extreme fear vs. regular dollar-cost averaging.

Crypto commentator Ran Neuner suggests limiting Bitcoin purchases to times of extreme market fear as an alternative to the common strategy of regular dollar-cost averaging (DCA). This approach focuses on timing buys to capitalize on market sentiment rather than spreading purchases evenly over time. The debate highlights different investor strategies for managing risk and maximizing returns in volatile crypto markets.

Ran Neuner's discussion on Bitcoin buying strategies is presented with Pluang market data as of Nov 10, 2026 18:41 WIB. For readers following major cryptocurrencies, 31 of 50 priced assets rose while 18 fell today. Notable movers include XNO (Nano) at Rp5.785 with a 3.23% increase and 100% buy order activity, AVAX (Avalanche) at Rp150.211 with a 3.13% rise, and LUNC (Terra Classic) at Rp0,721 with a 2.22% gain and 79% buy orders.

More News

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

Manufacturers expanding Microsoft 365 Copilot must review drawing revisions and supplier permissions to prevent data breaches.

The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...

Market News
Neutral
47 minutes ago
Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health chosen as specialty pharmacy partner for new FOP treatment Pasatru™

Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...

Market News
Bullish
47 minutes ago
PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera secures $25M to advance oral immunology drugs targeting TNFα and TL1A pathways.

PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...

Company Fundamentals
Bullish
47 minutes ago
Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics reports Q3 2026 results, advances gene therapy trials, and extends cash runway to 2029

Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...

Company Fundamentals
Bullish
47 minutes ago
Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group showcases new vehicles and tech at Fenatran 2026, boosting Latin America presence.

Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App